Business Context and Reporting Period
Company: TransBiotec, Inc. (Note: Request metadata listed "SOBR Safe, Inc.", but the filing text identifies the registrant as TransBiotec, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: August 23, 2019
Reporting Period: Events occurring on August 23, 2019, with share issuances occurring on or about August 28, 2019.
The filing details the entry into multiple material definitive agreements involving the issuance of common stock to officers, directors, and shareholders. These transactions were primarily executed to eliminate accrued liabilities and preferred stock to satisfy requirements for a pending Asset Purchase Agreement (APA) with IDTEC, LLC regarding robotics equipment.
Key Financial Metrics and Transactions
This filing does not contain standard financial statements (revenue, profit, cash flow, or margins). Instead, it reports specific capital structure changes and debt reductions:
- Debt Reduction via Stock Issuance:
- Charles Bennington (Officer/Director): $595,000 in accrued salary forgiven in exchange for 14,000,000 shares of common stock.
- Michael Lanphere (Officer): $96,303.35 in promissory note debt reduced in exchange for 21,400,745 shares of common stock.
- Devadatt Mishal (Director): $54,478.01 in promissory note debt reduced in exchange for 13,134,420 shares of common stock.
- Preferred Stock Conversions:
- Michael Lanphere: 520,643 shares of Series A Preferred Stock exchanged for 5,206,430 shares of common stock.
- Vernon Justus: 867,932 shares of Series A Preferred Stock exchanged for 8,679,320 shares of common stock.
- Total Common Stock Issued in Filing: 62,421,515 shares.
Material Changes Versus Prior Period
The filing does not provide comparative financial data against a prior period. However, it highlights a material change in the company's capital structure:
- Elimination of Preferred Stock: The company converted all outstanding Series A Preferred Stock held by Lanphere and Justus into common stock. This was a mandatory requirement under the APA with IDTEC, LLC, which prohibits any preferred stock from being outstanding.
- Reduction of Accrued Liabilities: Significant reductions in accrued salary and promissory note debt were achieved through equity issuance rather than cash payments.
- Share Count Expansion: The issuance of over 62 million shares represents a significant increase in the outstanding share count, though the pre-transaction total is not explicitly stated in the text.
Guidance, Outlook, and Risks
Strategic Outlook:
- The company is pursuing an acquisition of robotics equipment assets from IDTEC, LLC.
- Management believes these assets are synergistic with current operations.
- The acquisition consideration involves issuing common stock equal to 60% of the then-outstanding common stock.
- Dilution Risk: The issuance of 62+ million shares to insiders and the planned issuance of 60% of outstanding stock for the IDTEC acquisition pose significant dilution risks to existing shareholders.
- Related Party Transactions: All reported transactions involve officers, directors, or existing shareholders, raising potential conflicts of interest.
- Regulatory Compliance: The share issuances were exempt from registration under Section 4(a)(2) of the Securities Act of 1933 based on the recipients being sophisticated investors familiar with the company.
- The conversion of debt and preferred stock into common stock at specific ratios (e.g., 10:1 for preferred stock) suggests a low valuation per share or a strategic restructuring to facilitate the IDTEC deal.
Investor Verification Checklist
- Verify the total number of outstanding shares prior to these transactions to calculate the exact dilution percentage.
- Confirm the status of the Asset Purchase Agreement (APA) with IDTEC, LLC and whether the 60% stock issuance has been finalized.
- Review the full text of the attached exhibits (10.1 through 10.5) for specific terms regarding vesting, restrictions, or future obligations.
- Assess the company's current cash position and liquidity, as the filing indicates reliance on equity issuance to settle debts rather than cash flow.
- Investigate the valuation methodology used for the debt conversions and preferred stock exchanges to ensure fairness to minority shareholders.